Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, o... von Cunningham, David, Prof, Stenning, Sally P, Prof, Smyth, Elizabeth C, MBBCh, Okines, Alicia F, MD, Allum, William H, MD, Rowley, Sam, MSc, Stevenson, Laura, MSc, Grabsch, Heike I, Prof, Alderson, Derek, Prof, Crosby, Thomas, FRCR, Griffin, S Michael, Prof, Mansoor, Wasat, PhD, Coxon, Fareeda Y, MBBS, Falk, Stephen J, MD, Darby, Suzanne, MBChB, Sumpter, Kate A, MD, Blazeby, Jane M, Prof, Langley, Ruth E, Prof

Volltext

Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial von Ford, Hugo E R, Dr, Marshall, Andrea, PhD, Bridgewater, John A, PhD, Janowitz, Tobias, PhD, Coxon, Fareeda Y, MRCP, Wadsley, Jonathan, FRCR, Mansoor, Wasat, PhD, Fyfe, David, MD, Madhusudan, Srinivasan, FRCP, Middleton, Gary W, Prof, Swinson, Daniel, MD, Falk, Stephen, MD, Chau, Ian, MD, Cunningham, David, Prof, Kareclas, Paula, PhD, Cook, Natalie, PhD, Blazeby, Jane M, Prof, Dunn, Janet A, Prof

Volltext

Biomarker predication of efficacy to gemcitabine plus vandetanib in phase II, double blind multicentre randomised controlled trial of gemcitabine placebo in locally advanced or met... von Evans, Anthony, Jackson, Richard, Shaw, Victoria E., Ghaneh, Paula, Wadsley, Jonathan, Valle, Juan W., Wasan, Harpreet, Falk, Stephen, Cunningham, David, Coxon, Fareeda Y., Ross, Paul J., Wadd, Nick, Hickish, Tamas, Costello, Eithne, Campbell, Fiona, Rawcliffe, Charlotte, Neoptolemos, John P., Palmer, Daniel H., Greenhalf, William, Middleton, Gary

Volltext

Can Patients With Relapsed, Previously Untreated, Stage I Epithelial Ovarian Cancer Be Successfully Treated With Salvage Therapy? von KOLOMAINEN, Desiree F, A'HERN, Roger, COXON, Fareeda Y, FISHER, Cyril, KING, D. Michael, BLAKE, Peter R, BARTON, Desmond P. J, SHEPHERD, John H, KAYE, Stanley B, GORE, Martin E

Volltext

Evaluating maintenance therapies in advanced oesophago-gastric adenocarcinoma (OGA): Interim analysis and biomarker results from the PLATFORM study von Cunningham, David, Fong, Caroline Yean Kit, Peckitt, Clare, Anandappa, Gayathri, Davidson, Michael, Patel, Bijal, Turner, Andrea, Begum, Ruwaida, Cafferkey, Catherine, von Loga, Katharina, Rebelatto, Marlon, Petty, Russell D., Hewish, Madeleine, Roques, Tom, Coxon, Fareeda Y., Morgan, Carys, Wadsley, Jonathan, Waddell, Tom, Starling, Naureen, Chau, Ian

Volltext

Biomarker prediction of efficacy to vandetanib plus gemcitabine in a phase II double blind multicenter randomized placebo-controlled trial in locally advanced or metastatic pancrea... von Neoptolemos, John P., Palmer, Daniel, Greenhalf, William, Ghaneh, Paula, Jackson, Richard, Evans, Anthony, Shaw, Victoria, Wadsley, Jonathan, Valle, Juan W., Wasan, Harpreet, Falk, Stephen, Cunningham, David, Coxon, Fareeda Y., Ross, Paul J., Wadd, Nick, Hickish, Tamas, Costello, Eithne, Campbell, Fiona, Rawcliffe, Charlotte, Middleton, Gary William

Volltext

Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase... von Middleton, Gary, Palmer, Daniel H, Greenhalf, William, Ghaneh, Paula, Jackson, Richard, Cox, Trevor, Evans, Anthony G, Shaw, Victoria E, Wadsley, Jonathan, Valle, Juan, Propper, David, Wasan, Harpreet, Falk, Stephen, Cunningham, David, Coxon, Fareeda Y, Ross, R. Paul, Madhusudan, Srinivasan, Wadd, Nick, Corrie, Pippa, Hickish, Tamas, Costello, Eithne, Campbell, Fiona, Rawcliffe, Charlotte L, Neoptolemos, John

Volltext

Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: Results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072) von Alderson, Derek, Langley, Ruth E, Nankivell, Matthew Guy, Blazeby, Jane M., Griffin, Michael, Crellin, Adrian, Grabsch, Heike I., Okines, Alicia Frances Clare, Goldstein, Cindy, Falk, Stephen, Thompson, Joyce, Krysztopik, Richard, Coxon, Fareeda Y., Pritchard, Susan, Langer, Rupert, Stenning, Sally Patricia, Cunningham, David

Volltext

A phase III randomized trial of chemoimmunotherapy comprising gemcitabine and capecitabine with or without telomerase vaccine GV1001 in patients with locally advanced or metastatic... von Middleton, Gary William, Valle, Juan W., Wadsley, Jonathan, Propper, David, Coxon, Fareeda Y., Ross, Paul J., Madhusudan, Srinivasan, Roques, Tom, Cunningham, David, Corrie, Philippa, Greenhalf, William, Shaw, Victoria, Cox, Trevor F., Silcocks, Paul, Nanson, Gemma, Neoptolemos, John P.

Volltext

Cougar-02: A randomized phase III study of docetaxel versus active symptom control in patients with relapsed esophago-gastric adenocarcinoma von Cook, Natalie, Marshall, Andrea, Blazeby, Jane M., Bridgewater, John A., Wadsley, Jonathan, Coxon, Fareeda Y., Mansoor, Wasat, Madhusudan, Srinivasan, Falk, Stephen, Middleton, Gary William, Swinson, Daniel, Chau, Ian, Thompson, Joyce, Cunningham, David, Kareclas, Paula, Dunn, Janet A., Ford, Hugo

Volltext

A phase III randomized trial of chemoimmunotherapy comprising gemcitabine and capecitabine with or without telomerase vaccine GV1001 in patients with locally advanced or metastatic... von Middleton, Gary William, Valle, Juan W., Wadsley, Jonathan, Propper, David, Coxon, Fareeda Y., Ross, Paul J., Madhusudan, Srinivasan, Roques, Tom, Cunningham, David, Corrie, Philippa, Greenhalf, William, Shaw, Victoria, Cox, Trevor F., Silcocks, Paul, Nanson, Gemma, Neoptolemos, John P.

Volltext

Quality of life (QoL) analysis from the randomized phase III REAL3 trial of epirubicin, oxaliplatin, and capecitabine (EOC) with or without panitumumab (P) in advanced esophagogast... von Waddell, Tom Samuel, Chau, Ian, Peckitt, Clare, Gonzalez, David, Wotherspoon, Andrew, Patel, Bijal, Middleton, Gary William, Wadsley, Jonathan, Ferry, David, Mansoor, Wasat, Crosby, Tom David Lewis, Coxon, Fareeda Y., Smith, David, Waters, Justin S., Iveson, Timothy, Falk, Stephen, Slater, Sarah, Okines, Alicia Frances Clare, Cunningham, David

Volltext

Predictive cytokine biomarkers for survival in patients with advanced pancreatic cancer randomized to sequential chemoimmunotherapy comprising gemcitabine and capecitabine (GemCap)... von Neoptolemos, John P., Greenhalf, William, Cox, Trevor F., Costello, Eithne, Shaw, Victoria, Valle, Juan W., Coxon, Fareeda Y., Wadsley, Jonathan, Propper, David, Ross, Paul J., Madhusudan, Srinivasan, Roques, Tom, Cunningham, David, Eatock, Martin McKinlay, Iveson, Tim, Patel, Kinnari, Garcia-Alonso, Angel, Nanson, Gemma, Middleton, Gary

Volltext

COUGAR-02: A randomized phase III study of docetaxel versus active symptom control in advanced esophagogastric adenocarcinoma von Ford, Hugo, Marshall, Andrea, Wadsley, Jonathan, Coxon, Fareeda Y., Mansoor, Wasat, Bridgewater, John A., Madhusudan, Srinivasan, Falk, Stephen, Middleton, Gary William, Swinson, Daniel, Chau, Ian, Thompson, Joyce, Blazeby, Jane M., Cunningham, David, Kareclas, Paula, Dunn, Janet A.

Volltext

Prognostication in esophagogastric adenocarcinoma (OGA): Factors influencing overall survival (OS) in REAL3 von Waddell, Tom Samuel, Chau, Ian, Peckitt, Clare, Patel, Bijal, Gonzalez de Castro, David, Wotherspoon, Andrew, Middleton, Gary William, Wadsley, Jonathan, Ferry, David, Mansoor, Wasat, Crosby, Tom David Lewis, Coxon, Fareeda Y., Smith, David, Waters, Justin S., Iveson, Timothy, Falk, Stephen, Slater, Sarah, Okines, Alicia Frances Clare, Cunningham, David

Volltext

ST03: A randomized trial of perioperative epirubicin, cisplatin plus capecitabine (ECX) with or without bevacizumab (B) in patients (pts) with operable gastric, esophagogastric jun... von Smyth, Elizabeth Catherine, Langley, Ruth E., Stenning, Sally P., Stevenson, Laura, Robb, Claire, Allum, William H., Grabsch, Heike, Alderson, Derek, Riddell, Angela M., Crosby, Thomas, Mason, Robert, Griffin, Michael, Mansoor, Wasat, Coxon, Fareeda Y., Falk, Stephen, Furniss, Debra, Middleton, Gary William, Sumpter, Katherine Anne, Blazeby, Jane M., Cunningham, David

Volltext

A randomized multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) plus panitumumab in advanced esophagogastric cancer (REAL3) von Waddell, Tom Samuel, Chau, Ian, Barbachano, Yolanda, Gonzalez de Castro, David, Wotherspoon, Andrew, Saffery, Claire, Middleton, Gary William, Wadsley, Jonathan, Ferry, David Raymond, Mansoor, Wasat, Crosby, Tom David Lewis, Coxon, Fareeda Y, Smith, David, Waters, Justin S., Iveson, Timothy, Falk, Stephen, Slater, Sarah, Okines, Alicia Frances Clare, Cunningham, David

Volltext

A randomized, multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) plus panitumumab in advanced esophagogastric cancer (REAL3) von Waddell, Tom Samuel, Chau, Ian, Barbachano, Yolanda, Gonzalez de Castro, David, Wotherspoon, Andrew, Saffery, Claire, Middleton, Gary William, Wadsley, Jonathan, Ferry, David Raymond, Mansoor, Wasat, Crosby, Tom David Lewis, Coxon, Fareeda Y, Smith, David, Waters, Justin S., Iveson, Timothy, Falk, Stephen, Slater, Sarah, Okines, Alicia Frances Clare, Cunningham, David

Volltext

The place of polymer prodrugs in cancer therapy von Coxon, Fareeda Y, Cassidy, James

Volltext